SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-001983
Filing Date
2024-02-28
Accepted
2024-02-28 15:49:00
Documents
15
Period of Report
2024-02-26
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20240226x8k.htm   iXBRL 8-K 32959
  Complete submission text file 0001558370-24-001983.txt   173988

Data Files

Seq Description Document Type Size
2 EX-101.SCH ampe-20240226.xsd EX-101.SCH 3645
3 EX-101.LAB ampe-20240226_lab.xml EX-101.LAB 19420
4 EX-101.PRE ampe-20240226_pre.xml EX-101.PRE 13534
16 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20240226x8k_htm.xml XML 4858
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 24694891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)